Tower Research Capital (TRC)’s Kinnate Biopharma Inc. Common Stock KNTE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $2.9K | Sell |
|
|||||
|
2023
Q4 | $25.2K | Sell |
|
|||||
|
2023
Q3 | $15K | Sell |
|
|||||
|
2023
Q2 | $34.9K | Buy |
|
|||||
|
2023
Q1 | $20K | Buy |
|
|||||
|
2022
Q4 | $4K | Sell |
|
|||||
|
2022
Q3 | $83K | Buy |
|
|||||
|
2022
Q2 | $24K | Buy |
|
|||||
|
2022
Q1 | $9K | Sell |
|
|||||
|
2021
Q4 | $23K | Buy |
|
|||||
|
2021
Q3 | $12K | Sell |
|
|||||
|
2021
Q2 | $15K | Sell |
|
|||||
|
2021
Q1 | $20K | Buy |
|